AbbVie: Peers

The FY2025 (Dec) proxy of AbbVie names 9 peer companies for pay. Among AbbVie and these peers, CEO pay was 3rd highest of 8 and total shareholder return was 2nd highest of 8.

3rd highest of 8in AbbVie and its pay peers, FY2025 (Dec) by CEO pay:

$20.8M$36.7M

2nd highest of 8in AbbVie and its pay peers, FY2025 (Dec) by total shareholder return:

$86$671

Pay peer group, FY2025 (Dec) proxy

Eli Lilly & Co
Johnson & Johnson
Gilead Sciences
Pfizer
Amgen
Bristol Myers Squibb
Merck & Co.
GlaxoSmithKline plcNot disclosedNot disclosed
Novartis AGNot disclosedNot disclosed
9 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.